These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37415148)

  • 1. Isolated adrenocorticotropic hormone deficiency following immune checkpoint inhibitors treatment often occurs in polyglandular endocrinopathies.
    Chen H; Zhang L; Zhao L; Li X
    BMC Endocr Disord; 2023 Jul; 23(1):139. PubMed ID: 37415148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune checkpoint inhibitor-induced isolated adrenocorticotropic hormone deficiency: a systematic review.
    Wang F; Shi X; Yu X; Yang Y
    Front Endocrinol (Lausanne); 2024; 15():1326684. PubMed ID: 38318292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA investigation in ICI-induced T1D and isolated ACTH deficiency including meta-analysis.
    Ono M; Nagao M; Takeuchi H; Fukunaga E; Nagamine T; Inagaki K; Fukuda I; Iwabu M
    Eur J Endocrinol; 2024 Jul; 191(1):9-16. PubMed ID: 38917237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune Checkpoint Inhibitors-Induced Endocrinopathies: Assessment, Management and Monitoring in a Comprehensive Cancer Centre.
    Elshafie O; Khalil AB; Salman B; Atabani A; Al-Sayegh H
    Endocrinol Diabetes Metab; 2024 Jul; 7(4):e00505. PubMed ID: 38932429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-pituitary antibodies and susceptible human leukocyte antigen alleles as predictive biomarkers for pituitary dysfunction induced by immune checkpoint inhibitors.
    Kobayashi T; Iwama S; Sugiyama D; Yasuda Y; Okuji T; Ito M; Ito S; Sugiyama M; Onoue T; Takagi H; Hagiwara D; Ito Y; Suga H; Banno R; Nishikawa H; Arima H
    J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34011534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune checkpoint inhibitors and adrenal insufficiency: a large-sample case series study.
    Cui K; Wang Z; Zhang Q; Zhang X
    Ann Transl Med; 2022 Mar; 10(5):251. PubMed ID: 35402601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolated adrenocorticotropic hormone deficiency associated with sintilimab therapy in a patient with advanced lung adenocarcinoma: a case report and literature review.
    Lin SH; Zhang A; Li LZ; Zhao LC; Wu LX; Fang CT
    BMC Endocr Disord; 2022 Sep; 22(1):239. PubMed ID: 36153581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy-induced isolated ACTH deficiency in cancer therapy.
    Iglesias P; Peiró I; Biagetti B; Paja-Fano M; Cobo DA; García Gómez C; Mateu-Salat M; Genua I; Majem M; Riudavets M; Gavira J; Lamas C; Fernández Pombo A; Guerrero-Pérez F; Villabona C; Cabezas Agrícola JM; Webb SM; Díez JJ
    Endocr Relat Cancer; 2021 Oct; 28(12):783-792. PubMed ID: 34609950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolated ACTH deficiency induced by cancer immunotherapy: a systematic review.
    Iglesias P; Sánchez JC; Díez JJ
    Pituitary; 2021 Aug; 24(4):630-643. PubMed ID: 33761049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid Immune-related Adverse Events Following Immune Checkpoint Inhibitor Treatment.
    Muir CA; Clifton-Bligh RJ; Long GV; Scolyer RA; Lo SN; Carlino MS; Tsang VHM; Menzies AM
    J Clin Endocrinol Metab; 2021 Aug; 106(9):e3704-e3713. PubMed ID: 33878162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pituitary immune-related adverse events induced by programmed cell death protein 1 inhibitors in advanced lung cancer patients: A report of 3 cases].
    Gu YC; Liu Y; Xie C; Cao BS
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 54(2):369-375. PubMed ID: 35435206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrum of immune checkpoint inhibitors-induced endocrinopathies in cancer patients: a scoping review of case reports.
    Tan MH; Iyengar R; Mizokami-Stout K; Yentz S; MacEachern MP; Shen LY; Redman B; Gianchandani R
    Clin Diabetes Endocrinol; 2019; 5():1. PubMed ID: 30693099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolated autoimmune adrenocorticotropic hormone deficiency: From a rare disease to the dominant cause of adrenal insufficiency related to check point inhibitors.
    Percik R; Shlomai G; Tirosh A; Tirosh A; Leibowitz-Amit R; Eshet Y; Greenberg G; Merlinsky A; Barhod E; Steinberg-Silman Y; Sella T
    Autoimmun Rev; 2020 Feb; 19(2):102454. PubMed ID: 31838158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune Checkpoint Inhibitor-related New-onset Thyroid Dysfunction: A Retrospective Analysis Using the US FDA Adverse Event Reporting System.
    Lu D; Yao J; Yuan G; Gao Y; Zhang J; Guo X
    Oncologist; 2022 Mar; 27(2):e126-e132. PubMed ID: 35641200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA analysis of immune checkpoint inhibitor-induced and idiopathic isolated ACTH deficiency.
    Ono M; Fukuda I; Nagao M; Tomiyama K; Okazaki-Hada M; Shuto Y; Kobayashi S; Yamaguchi Y; Nagamine T; Nakajima Y; Inagaki-Tanimura K; Sugihara H
    Pituitary; 2022 Aug; 25(4):615-621. PubMed ID: 35653047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolated Adrenocorticotropic Hormone Deficiency and Primary Hypothyroidism in a Patient Undergoing Long-Term Hemodialysis: A Case Report and Literature Review.
    Ohara N; Kobayashi M; Tuchida M; Koda R; Yoneoka Y; Iino N
    Am J Case Rep; 2020 Apr; 21():e922376. PubMed ID: 32343680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypophysitis and Secondary Adrenal Insufficiency From Immune Checkpoint Inhibitors: Diagnostic Challenges and Link With Survival.
    Johnson J; Goldner W; Abdallah D; Qiu F; Ganti AK; Kotwal A
    J Natl Compr Canc Netw; 2023 Feb; 21(3):281-287. PubMed ID: 36828029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal Thyroid Hormone Replacement Dose in Immune Checkpoint Inhibitor-Associated Hypothyroidism Is Distinct from Hashimoto's Thyroiditis.
    Mosaferi T; Tsai K; Sovich S; Wilhalme H; Kathuria-Prakash N; Praw SS; Drakaki A; Angell TE; Lechner MG
    Thyroid; 2022 May; 32(5):496-504. PubMed ID: 35199588
    [No Abstract]   [Full Text] [Related]  

  • 19. Endocrine toxicity of immune checkpoint inhibitors: a real-world study leveraging US Food and Drug Administration adverse events reporting system.
    Zhai Y; Ye X; Hu F; Xu J; Guo X; Zhuang Y; He J
    J Immunother Cancer; 2019 Nov; 7(1):286. PubMed ID: 31694698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrinopathies Associated With Immune Checkpoint Inhibitor Use.
    Kotwal A; Kennedy R; Kikani N; Thosani S; Goldner W; Shariff A
    Endocr Pract; 2024 Jun; 30(6):584-591. PubMed ID: 38554775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.